CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-07 | Brown Ryan Edward SVP, General Counsel | Grant or award · Stock Option (right to buy) | +48,000 | 48,000 | ||
| 2022-03-07 | Ciambrone William EVP | Grant or award | +8,000 | 22,099 | ||
| 2022-03-07 | Ciambrone William EVP | Grant or award · Stock Option (right to buy) | +48,000 | 48,000 | ||
| 2022-03-07 | Rodino-Klapac Louise Head of R&D, CSO | Grant or award | +8,000 | 72,111 | ||
| 2022-03-07 | Rodino-Klapac Louise Head of R&D, CSO | Grant or award · Stock Option (right to buy) | +48,000 | 48,000 | ||
| 2022-03-04 | Estepan Ian Michael Chief Financial Officer | Shares withheld for taxes | −1,308 | $79.20 | $104K | 25,069 |
| 2022-03-04 | Brown Ryan Edward SVP, General Counsel | Shares withheld for taxes | −1,136 | $79.20 | $90K | 18,048 |
| 2022-03-04 | Ciambrone William EVP | Shares withheld for taxes | −1,160 | $79.20 | $92K | 14,099 |
| 2022-03-04 | Rodino-Klapac Louise Head of R&D, CSO | Shares withheld for taxes | −1,216 | $79.20 | $96K | 64,111 |
| 2022-03-01 | Rodino-Klapac Louise Head of R&D, CSO | Shares withheld for taxes | −572 | $75.05 | $43K | 65,327 |
| 2022-03-01 | Estepan Ian Michael Chief Financial Officer | Shares withheld for taxes | −376 | $75.05 | $28K | 26,377 |
| 2022-03-01 | Brown Ryan Edward SVP, General Counsel | Shares withheld for taxes | −184 | $75.05 | $14K | 19,184 |
| 2021-12-15 | BEHRENS M KATHLEEN Director | Exercise or conversion | +5,000 | $10.08 | $50K | 135,517 |
| 2021-12-15 | BEHRENS M KATHLEEN Director | Exercise or conversion · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2021-12-10 | GRAY MARY ANN Director | Exercise or conversion | +967 | 9,403 | ||
| 2021-12-10 | GRAY MARY ANN Director | Exercise or conversion · Restricted Stock Units | −967 | 0 | ||
| 2021-11-24 | Rodino-Klapac Louise Head of R&D, CSO | Purchase | +3,780 | $79.33 | $300K | 65,678 |
| 2021-11-17 | INGRAM DOUGLAS S President & CEO | Purchase | +25,026 | $79.94 | $2.0M | 365,082 |
| 2021-11-16 | Mayo Stephen Director | Grant or award | +4,292 | 4,292 | ||
| 2021-11-16 | Mayo Stephen Director | Grant or award · Stock Option (right to buy) | +8,238 | 8,238 |
Page 19 of 22 · 424 trades